Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.